Efficacy and safety of SGLT2 inhibitors in nondiabetic patients with CKD: a review of recent evidence

• मुख्य लेखकों: Junhao Lv (लेखक), Luying Guo (लेखक), Rending Wang (लेखक), Jianghua Chen (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Karger Publishers, 2023-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) were initially developed as glucose-lowering agents in patients with type-2 diabetes. However, available data from clinical trials and meta-analyses suggest that SGLT2i have pleiotropic benefits in reducing mortality and delaying the pro...